Total Fourth-Quarter and Full-Year 2025 Net Product Sales of $798.3 Million and $2.83 Billion, Representing Year-Over-Year Growth of 29% and 22%, Respectively INGREZZA® (valbenazine) Full Year 2026 Net Product Sales Guidance of $2.7 – $2.8 Billion SAN DIEGO, Feb. 11, 2026 /PRNewswire/ –…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
